Differentially Expressed Proteins in Sporadic Parathyroid Tumors
Identification of Differentially Expressed Proteins in Parathyroid Tumors and Their Clinical Correlation With the Disease
1 other identifier
observational
50
1 country
1
Brief Summary
Primary hyperparathyroidism (PHPT) is one of the common endocrine disorders. The major clinical symptoms involve stones, bones, abdominal groans and psychiatric moans. Increased parathyroid cell proliferation and decreased calcium-mediated control of the PTH secretion are characteristic findings. The most common cause of PHPT is adenoma followed by hyperplasia and carcinoma.The molecular mechanisms involved in parathyroid tumorigenesis are partially known. Few genes have been identified and their roles are under study. The genes which are under study by different groups are unable to give a definite direction towards the understanding of parathyroid tumorigenesis and the mechanism involved in overgrowth of parathyroid tissue. So identifying different proteins and their regulation pattern from adenomas to carcinomas will be the initial steps towards understanding the proteins involved in tumorigenesis of parathyroid tissues. By using proteomics approach one can generate protein level information. In this study, using a combined approach based on 2 D gel electrophoresis and mass spectrometry (MS), the investigators propose to study a comparative proteomics to examine the changes of protein profiles in parathyroid tumor tissues with normal and hyperplasic parathyroid tissues. This work plan will help us to understand differentially expressed proteins in patients with PHPT. This will help in understanding the disease and identifying better diagnostic and curative measures of the disease. The investigators are also planning to access nuclear morphometry changes in sporadic parathyroid tumors. It will help in establishing cellular and nuclear change pattern variations from normal to parathyroid tumors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2012
CompletedFirst Submitted
Initial submission to the registry
July 18, 2012
CompletedFirst Posted
Study publicly available on registry
July 23, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2015
CompletedApril 16, 2014
April 1, 2014
3.2 years
July 18, 2012
April 15, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Differentially expressed proteins in parathyroid adenomas tissue samples
At the end of three years of the study
Study Arms (2)
Tumor group
Parathyroid adenoma, hyperplasia and carcinoma
Normal
Normal parathyroid samples
Eligibility Criteria
Patients visiting the hospital for hypercalcemia, bone pain, renal problems and other symptoms related to primary hyperparathyroidim will be consider. Investigations and clinical symptoms will be confirmed for primary hyperpathyroidism. Finally if patient suggested for surgery then he will be included in the study
You may qualify if:
- PHPT patients with parathyroid adenoma, hyperplasia and carcinoma
You may not qualify if:
- Patients with family history, HPT-JT syndrome and familial isolated hyperparathyroidism
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
PGIMER
Chandigarh, Uttarakhand, 1600012, India
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sanjay Kr Bhadada, DM
Associate Professor, Department of Endocrinology, PGIMER Chandigarh India
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor, Dept of Endocrinology
Study Record Dates
First Submitted
July 18, 2012
First Posted
July 23, 2012
Study Start
July 1, 2012
Primary Completion
September 1, 2015
Last Updated
April 16, 2014
Record last verified: 2014-04